Are we out of the woods yet? According to the OECD's latest Economic Outlook, COVID-19 has been causing enormous damage to people's health, jobs, and well-being. Furthermore, due to this pandemic and the associated global healthcare crisis, supply chains have faced significant disruptions in the pharmaceutical world. The recovery road and the new normal in the pharmaceutical industry are beginning to shine as we enter the new fiscal year 2023-2024.
During a health emergency response, leaders must make numerous critical decisions for the supply chain and prevention strategies (Glasser, Hupert, McCauley, and Hatchett, 2011). The decisions occur in a rapidly changing environment and need to be more informed or biased. Consequently, forecasting becomes essential for helping and guiding the utility and timing of go-to market strategies.
However, using historical forecasts for decision-making is challenging because the landscape has changed, and so the uncertainties that existed in 2019 are now the "new normal." Each forecasting output created has limitations. Furthermore, historical data may not be reliable because it may have been recorded during emergencies. As a result, comparing forecasts at the country or regional level remains challenging, potentially limiting the development and utility of projections.
There are many ways a forecaster approaches the forecast; no cookie-cutter method or answer exists. However, there certainly are some best practices that have been successful in the post-COVID-19 years.
Looking for 'True Insights gap'
This story is from the April 2023 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 2023 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.